sales@marketbusinessinsights.com | +1 (518)-300-1070
Market Business Insights Vaccine for Influenza Market
Request Sample Buy Now

Table Of Contents 

1 Study Coverage
    1.1 Vaccine for Influenza Product Introduction
    1.2 Market by Type
        1.2.1 Global Vaccine for Influenza Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Market by Application
        1.3.1 Global Vaccine for Influenza Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Vaccine for Influenza Sales Estimates and Forecasts 2017-2028
    2.2 Global Vaccine for Influenza Revenue Estimates and Forecasts 2017-2028
    2.3 Global Vaccine for Influenza Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Vaccine for Influenza Sales by Region
        2.4.1 Global Vaccine for Influenza Sales by Region (2017-2022)
        2.4.2 Global Sales Vaccine for Influenza by Region (2023-2028)
    2.5 Global Vaccine for Influenza Revenue by Region
        2.5.1 Global Vaccine for Influenza Revenue by Region (2017-2022)
        2.5.2 Global Vaccine for Influenza Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Vaccine for Influenza Sales by Manufacturers
        3.1.1 Global Top Vaccine for Influenza Manufacturers by Sales (2017-2022)
        3.1.2 Global Vaccine for Influenza Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine for Influenza in 2021
    3.2 Global Vaccine for Influenza Revenue by Manufacturers
        3.2.1 Global Vaccine for Influenza Revenue by Manufacturers (2017-2022)
        3.2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Vaccine for Influenza Revenue in 2021
    3.3 Global Vaccine for Influenza Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Vaccine for Influenza Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Vaccine for Influenza Sales by Type
        4.1.1 Global Vaccine for Influenza Historical Sales by Type (2017-2022)
        4.1.2 Global Vaccine for Influenza Forecasted Sales by Type (2023-2028)
        4.1.3 Global Vaccine for Influenza Sales Market Share by Type (2017-2028)
    4.2 Global Vaccine for Influenza Revenue by Type
        4.2.1 Global Vaccine for Influenza Historical Revenue by Type (2017-2022)
        4.2.2 Global Vaccine for Influenza Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    4.3 Global Vaccine for Influenza Price by Type
        4.3.1 Global Vaccine for Influenza Price by Type (2017-2022)
        4.3.2 Global Vaccine for Influenza Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Vaccine for Influenza Sales by Application
        5.1.1 Global Vaccine for Influenza Historical Sales by Application (2017-2022)
        5.1.2 Global Vaccine for Influenza Forecasted Sales by Application (2023-2028)
        5.1.3 Global Vaccine for Influenza Sales Market Share by Application (2017-2028)
    5.2 Global Vaccine for Influenza Revenue by Application
        5.2.1 Global Vaccine for Influenza Historical Revenue by Application (2017-2022)
        5.2.2 Global Vaccine for Influenza Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    5.3 Global Vaccine for Influenza Price by Application
        5.3.1 Global Vaccine for Influenza Price by Application (2017-2022)
        5.3.2 Global Vaccine for Influenza Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Vaccine for Influenza Market Size by Type
        6.1.1 North America Vaccine for Influenza Sales by Type (2017-2028)
        6.1.2 North America Vaccine for Influenza Revenue by Type (2017-2028)
    6.2 North America Vaccine for Influenza Market Size by Application
        6.2.1 North America Vaccine for Influenza Sales by Application (2017-2028)
        6.2.2 North America Vaccine for Influenza Revenue by Application (2017-2028)
    6.3 North America Vaccine for Influenza Market Size by Country
        6.3.1 North America Vaccine for Influenza Sales by Country (2017-2028)
        6.3.2 North America Vaccine for Influenza Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Vaccine for Influenza Market Size by Type
        7.1.1 Europe Vaccine for Influenza Sales by Type (2017-2028)
        7.1.2 Europe Vaccine for Influenza Revenue by Type (2017-2028)
    7.2 Europe Vaccine for Influenza Market Size by Application
        7.2.1 Europe Vaccine for Influenza Sales by Application (2017-2028)
        7.2.2 Europe Vaccine for Influenza Revenue by Application (2017-2028)
    7.3 Europe Vaccine for Influenza Market Size by Country
        7.3.1 Europe Vaccine for Influenza Sales by Country (2017-2028)
        7.3.2 Europe Vaccine for Influenza Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Vaccine for Influenza Market Size by Type
        8.1.1 Asia Pacific Vaccine for Influenza Sales by Type (2017-2028)
        8.1.2 Asia Pacific Vaccine for Influenza Revenue by Type (2017-2028)
    8.2 Asia Pacific Vaccine for Influenza Market Size by Application
        8.2.1 Asia Pacific Vaccine for Influenza Sales by Application (2017-2028)
        8.2.2 Asia Pacific Vaccine for Influenza Revenue by Application (2017-2028)
    8.3 Asia Pacific Vaccine for Influenza Market Size by Region
        8.3.1 Asia Pacific Vaccine for Influenza Sales by Region (2017-2028)
        8.3.2 Asia Pacific Vaccine for Influenza Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Vaccine for Influenza Market Size by Type
        9.1.1 Latin America Vaccine for Influenza Sales by Type (2017-2028)
        9.1.2 Latin America Vaccine for Influenza Revenue by Type (2017-2028)
    9.2 Latin America Vaccine for Influenza Market Size by Application
        9.2.1 Latin America Vaccine for Influenza Sales by Application (2017-2028)
        9.2.2 Latin America Vaccine for Influenza Revenue by Application (2017-2028)
    9.3 Latin America Vaccine for Influenza Market Size by Country
        9.3.1 Latin America Vaccine for Influenza Sales by Country (2017-2028)
        9.3.2 Latin America Vaccine for Influenza Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Vaccine for Influenza Market Size by Type
        10.1.1 Middle East and Africa Vaccine for Influenza Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Vaccine for Influenza Revenue by Type (2017-2028)
    10.2 Middle East and Africa Vaccine for Influenza Market Size by Application
        10.2.1 Middle East and Africa Vaccine for Influenza Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Vaccine for Influenza Revenue by Application (2017-2028)
    10.3 Middle East and Africa Vaccine for Influenza Market Size by Country
        10.3.1 Middle East and Africa Vaccine for Influenza Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Vaccine for Influenza Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 CSL
        11.2.1 CSL Corporation Information
        11.2.2 CSL Overview
        11.2.3 CSL Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CSL Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CSL Recent Developments
    11.3 GSK
        11.3.1 GSK Corporation Information
        11.3.2 GSK Overview
        11.3.3 GSK Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GSK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GSK Recent Developments
    11.4 Mylan
        11.4.1 Mylan Corporation Information
        11.4.2 Mylan Overview
        11.4.3 Mylan Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mylan Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mylan Recent Developments
    11.5 Hulan Bio
        11.5.1 Hulan Bio Corporation Information
        11.5.2 Hulan Bio Overview
        11.5.3 Hulan Bio Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hulan Bio Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hulan Bio Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Corporation Information
        11.6.2 AstraZeneca Overview
        11.6.3 AstraZeneca Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 AstraZeneca Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 AstraZeneca Recent Developments
    11.7 CCBIO
        11.7.1 CCBIO Corporation Information
        11.7.2 CCBIO Overview
        11.7.3 CCBIO Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 CCBIO Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 CCBIO Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Vaccine for Influenza Industry Chain Analysis
    12.2 Vaccine for Influenza Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Vaccine for Influenza Production Mode & Process
    12.4 Vaccine for Influenza Sales and Marketing
        12.4.1 Vaccine for Influenza Sales Channels
        12.4.2 Vaccine for Influenza Distributors
    12.5 Vaccine for Influenza Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Vaccine for Influenza Industry Trends
    13.2 Vaccine for Influenza Market Drivers
    13.3 Vaccine for Influenza Market Challenges
    13.4 Vaccine for Influenza Market Restraints
14 Key Findings in The Global Vaccine for Influenza Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Vaccine for Influenza Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Trivalent Influenza Vaccine
    Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
    Table 4. Global Vaccine for Influenza Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Vaccine for Influenza Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Vaccine for Influenza Sales by Region (2017-2022) & (K Units)
    Table 7. Global Vaccine for Influenza Sales Market Share by Region (2017-2022)
    Table 8. Global Vaccine for Influenza Sales by Region (2023-2028) & (K Units)
    Table 9. Global Vaccine for Influenza Sales Market Share by Region (2023-2028)
    Table 10. Global Vaccine for Influenza Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Vaccine for Influenza Revenue Market Share by Region (2017-2022)
    Table 12. Global Vaccine for Influenza Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Vaccine for Influenza Revenue Market Share by Region (2023-2028)
    Table 14. Global Vaccine for Influenza Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Vaccine for Influenza Sales Share by Manufacturers (2017-2022)
    Table 16. Global Vaccine for Influenza Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Vaccine for Influenza Revenue Share by Manufacturers (2017-2022)
    Table 18. Vaccine for Influenza Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2021)
    Table 21. Vaccine for Influenza Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Vaccine for Influenza Product Offered
    Table 23. Date of Manufacturers Enter into Vaccine for Influenza Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 26. Global Vaccine for Influenza Sales by Type (2023-2028) & (K Units)
    Table 27. Global Vaccine for Influenza Sales Share by Type (2017-2022)
    Table 28. Global Vaccine for Influenza Sales Share by Type (2023-2028)
    Table 29. Global Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Vaccine for Influenza Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Vaccine for Influenza Revenue Share by Type (2017-2022)
    Table 32. Global Vaccine for Influenza Revenue Share by Type (2023-2028)
    Table 33. Vaccine for Influenza Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Vaccine for Influenza Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Vaccine for Influenza Sales by Application (2017-2022) & (K Units)
    Table 36. Global Vaccine for Influenza Sales by Application (2023-2028) & (K Units)
    Table 37. Global Vaccine for Influenza Sales Share by Application (2017-2022)
    Table 38. Global Vaccine for Influenza Sales Share by Application (2023-2028)
    Table 39. Global Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Vaccine for Influenza Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Vaccine for Influenza Revenue Share by Application (2017-2022)
    Table 42. Global Vaccine for Influenza Revenue Share by Application (2023-2028)
    Table 43. Vaccine for Influenza Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Vaccine for Influenza Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 46. North America Vaccine for Influenza Sales by Type (2023-2028) & (K Units)
    Table 47. North America Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Vaccine for Influenza Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Vaccine for Influenza Sales by Application (2017-2022) & (K Units)
    Table 50. North America Vaccine for Influenza Sales by Application (2023-2028) & (K Units)
    Table 51. North America Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Vaccine for Influenza Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 54. North America Vaccine for Influenza Sales by Country (2023-2028) & (K Units)
    Table 55. North America Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Vaccine for Influenza Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Vaccine for Influenza Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Vaccine for Influenza Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Vaccine for Influenza Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Vaccine for Influenza Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Vaccine for Influenza Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Vaccine for Influenza Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Vaccine for Influenza Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Vaccine for Influenza Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Vaccine for Influenza Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Vaccine for Influenza Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Vaccine for Influenza Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Vaccine for Influenza Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Vaccine for Influenza Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Vaccine for Influenza Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Vaccine for Influenza Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Vaccine for Influenza Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Vaccine for Influenza Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Vaccine for Influenza Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Vaccine for Influenza Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Vaccine for Influenza Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Vaccine for Influenza Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Vaccine for Influenza Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Vaccine for Influenza Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Vaccine for Influenza Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Vaccine for Influenza Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Vaccine for Influenza Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Vaccine for Influenza Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Vaccine for Influenza Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Vaccine for Influenza Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Vaccine for Influenza Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Sanofi Corporation Information
    Table 106. Sanofi Description and Major Businesses
    Table 107. Sanofi Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Sanofi Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Sanofi Recent Developments
    Table 110. CSL Corporation Information
    Table 111. CSL Description and Major Businesses
    Table 112. CSL Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. CSL Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. CSL Recent Developments
    Table 115. GSK Corporation Information
    Table 116. GSK Description and Major Businesses
    Table 117. GSK Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. GSK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. GSK Recent Developments
    Table 120. Mylan Corporation Information
    Table 121. Mylan Description and Major Businesses
    Table 122. Mylan Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Mylan Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Mylan Recent Developments
    Table 125. Hulan Bio Corporation Information
    Table 126. Hulan Bio Description and Major Businesses
    Table 127. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Hulan Bio Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Hulan Bio Recent Developments
    Table 130. AstraZeneca Corporation Information
    Table 131. AstraZeneca Description and Major Businesses
    Table 132. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. AstraZeneca Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. AstraZeneca Recent Developments
    Table 135. CCBIO Corporation Information
    Table 136. CCBIO Description and Major Businesses
    Table 137. CCBIO Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. CCBIO Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. CCBIO Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Vaccine for Influenza Distributors List
    Table 143. Vaccine for Influenza Customers List
    Table 144. Vaccine for Influenza Market Trends
    Table 145. Vaccine for Influenza Market Drivers
    Table 146. Vaccine for Influenza Market Challenges
    Table 147. Vaccine for Influenza Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine for Influenza Product Picture
    Figure 3. Global Vaccine for Influenza Market Share by Type in 2021 & 2028
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Vaccine for Influenza Market Share by Application in 2021 & 2028
    Figure 6. For Children (6 months to 3 years)
    Figure 7. For Adults and Children over 3 years
    Figure 8. Vaccine for Influenza Report Years Considered
    Figure 9. Global Vaccine for Influenza Sales 2017-2028 (K Units)
    Figure 10. Global Vaccine for Influenza Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Vaccine for Influenza Revenue 2017-2028 (US$ Million)
    Figure 12. Global Vaccine for Influenza Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Vaccine for Influenza Sales Market Share by Region (2017-2022)
    Figure 14. Global Vaccine for Influenza Sales Market Share by Region (2023-2028)
    Figure 15. North America Vaccine for Influenza Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Vaccine for Influenza Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Vaccine for Influenza Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Vaccine for Influenza Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Vaccine for Influenza Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Vaccine for Influenza Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Vaccine for Influenza Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Vaccine for Influenza Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Vaccine for Influenza Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Vaccine for Influenza Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Vaccine for Influenza Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Vaccine for Influenza in the World: Market Share by Vaccine for Influenza Revenue in 2021
    Figure 27. Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Vaccine for Influenza Sales Market Share by Type (2017-2028)
    Figure 29. Global Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    Figure 30. Global Vaccine for Influenza Sales Market Share by Application (2017-2028)
    Figure 31. Global Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    Figure 32. North America Vaccine for Influenza Sales Market Share by Type (2017-2028)
    Figure 33. North America Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    Figure 34. North America Vaccine for Influenza Sales Market Share by Application (2017-2028)
    Figure 35. North America Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    Figure 36. North America Vaccine for Influenza Sales Share by Country (2017-2028)
    Figure 37. North America Vaccine for Influenza Revenue Share by Country (2017-2028)
    Figure 38. U.S. Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Vaccine for Influenza Sales Market Share by Type (2017-2028)
    Figure 41. Europe Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Vaccine for Influenza Sales Market Share by Application (2017-2028)
    Figure 43. Europe Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Vaccine for Influenza Sales Share by Country (2017-2028)
    Figure 45. Europe Vaccine for Influenza Revenue Share by Country (2017-2028)
    Figure 46. Germany Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 47. France Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Vaccine for Influenza Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Vaccine for Influenza Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Vaccine for Influenza Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Vaccine for Influenza Revenue Share by Region (2017-2028)
    Figure 57. China Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 60. India Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Vaccine for Influenza Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Vaccine for Influenza Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Vaccine for Influenza Sales Share by Country (2017-2028)
    Figure 71. Latin America Vaccine for Influenza Revenue Share by Country (2017-2028)
    Figure 72. Mexico Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Vaccine for Influenza Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Vaccine for Influenza Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Vaccine for Influenza Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Vaccine for Influenza Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Vaccine for Influenza Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Vaccine for Influenza Revenue Share by Country (2017-2028)
    Figure 81. Turkey Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Vaccine for Influenza Revenue (2017-2028) & (US$ Million)
    Figure 84. Vaccine for Influenza Value Chain
    Figure 85. Vaccine for Influenza Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
  1. Global Market, By Product Types, 2018-2028 (USD Million)
  2. Global Market, By Applications, 2018-2028 (USD Million)
  3. Global Secure Messaging, Vaccine for Influenza Market, By Region, 2018-2028 (USD Million)
  4. Global Web Portal, Vaccine for Influenza Market, By Region, 2018-2028 (USD Million)
  5. Global Private, Vaccine for Influenza Market, By Region, 2018-2028 (USD Million)
  6. Global Public,Vaccine for Influenza Market, By Region, 2018-2028 (USD Million)
  7. North America Market, By Product Types, 2018-2028 (USD Million)
  8. North America Market, By Applications, 2018-2028 (USD Million)
  9. U.S. Market, By Product Types, 2018-2028 (USD Million)
  10. U.S. Market, By Applications, 2018-2028 (USD Million)
  11. Canada Market, By Product Types, 2018-2028 (USD Million)
  12. Canada Market, By Applications, 2018-2028 (USD Million)
  13. Mexico Market, By Product Types, 2018-2028 (USD Million)
  14. Mexico Market, By Applications, 2018-2028 (USD Million)
  15. Europe Market, By Product Types, 2018-2028 (USD Million)
  16. Europe Market, By Applications, 2018-2028 (USD Million)
  17. U.K. Market, By Product Types, 2018-2028 (USD Million)
  18. U.K. Market, By Applications, 2018-2028 (USD Million)
  19. Germany Market, By Product Types, 2018-2028 (USD Million)
  20. Germany Market, By Applications, 2018-2028 (USD Million)
  21. Italy Market, By Product Types, 2018-2028 (USD Million)
  22. Italy Market, By Applications, 2018-2028 (USD Million)
  23. France Market, By Product Types, 2018-2028 (USD Million)
  24. France Market, By Applications, 2018-2028 (USD Million)
  25. Russia Market, By Product Types, 2018-2028 (USD Million)
  26. Russia Market, By Applications, 2018-2028 (USD Million)
  27. Asia-Pacific Market, By Product Types, 2018-2028 (USD Million)
  28. Asia-Pacific Market, By Applications, 2018-2028 (USD Million)
  29. India Market, By Product Types, 2018-2028 (USD Million)
  30. India Market, By Applications, 2018-2028 (USD Million)
  31. Japan Market, By Product Types, 2018-2028 (USD Million)
  32. Japan Market, By Applications, 2018-2028 (USD Million)
  33. China Market, By Product Types, 2018-2028 (USD Million)
  34. China Market, By Applications, 2018-2028 (USD Million)
  35. South Korea Market, By Product Types, 2018-2028 (USD Million)
  36. South Korea Market, By Applications, 2018-2028 (USD Million)
  37. Australia Market, By Product Types, 2018-2028 (USD Million)
  38. Australia Market, By Applications, 2018-2028 (USD Million)
  39. Latin America Market, By Product Types, 2018-2028 (USD Million)
  40. Latin America Market, By Applications, 2018-2028 (USD Million)
  41. Brazil Market, By Product Types, 2018-2028 (USD Million)
  42. Brazil Market, By Applications, 2018-2028 (USD Million)
  43. Middle East & Africa Market, By Product Types, 2018-2028 (USD Million)
  44. Middle East & Africa Market, By Applications, 2018-2028 (USD Million)
  45. Saudi Arabia Market, By Product Types, 2018-2028 (USD Million)
  46. Saudi Arabia Market, By Applications, 2018-2028 (USD Million)
  47. UAE Market, By Product Types, 2018-2028 (USD Million)
  48. UAE Market, By Applications, 2018-2028 (USD Million)
  49. South Africa Market, By Product Types, 2018-2028 (USD Million)
  50. South Africa Market, By Applications, 2018-2028 (USD Million)
  1. Global Vaccine for Influenza Market Segmentation
  2. Global Vaccine for Influenza Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global Market Attractiveness Analysis By Product Types
  9. Global Market Attractiveness Analysis By Applications
  10. Global Vaccine for Influenza Market Attractiveness Analysis ByRegion
  11. Global Vaccine for Influenza Market: Dynamics
  12. Global Market Share By Product Types (2021 & 2028)
  13. Global Market Share By Applications (2021 & 2028)
  14. Global Vaccine for Influenza Market Share By Region (2021 & 2028)
  15. Global Vaccine for Influenza Market Share By Company (2020)
We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports